Glucagon-Like-Peptide-1 Receptor Agonists: The Gift That Keeps on Giving [pro bio health keto gummies]

Glucagon-Like-Peptide-1 Receptor Agonists: The Gift That Keeps on Giving [pro bio health keto gummies]

| 1h 28m 28s | Video has closed captioning.

Learning Objectives: 1. Discuss the clinical effects of glucagon-like-peptide-1 receptor agonists. 2. Describe the latest evidence for use in chronic kidney disease and new research studies in the field. Dr. Kevin Yau received his medical degree from the University of Toronto in 2016 and completed Internal Medicine training at Western University. He subsequently completed general nephrology fellowship and a Cardiovascular, Renal, Endocrinology and Metabolic Diseases Fellowship and a Master’s in Clinical Epidemiology at the University of Toronto. He is currently a Glomerulonephritis Fellow and will be joining the Division of Nephrology at the University Health Network as a Clinician Scientist. His research has focused on use of glucagon-like peptide-1 receptor agonists in CKD, clinical trials and glomerulonephritis.